3 internationally renowned R&D centers

Ipsen has set-up its R&D centers at the heart of three internationally reputed scientific hubs: Paris-Saclay in France, Oxford in United Kingdom and Cambridge in United States of America. Each site is located close to leading academic research centers, cutting edge medical centers and biotechnological companies. The interactions with these different players in the health industry develop our chances of having access to innovative technologies in order to speed up the discovery and commissioning of drugs and services that improve the lives of patients.

The R&D center at Les Ulis is located in the Paris-Saclay hub which is home to several thousand life sciences researchers. Ipsen’s innovation teams are housed in a high-tech environment, in close contact with major scientific and academic institutions, such as Ecole Polytechnique, the French National Center for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM) and the Atomic Energy Commission (CEA).

One of the missions of Ipsen’s largest R&D site, established in 1969, is to accelerate clinical development and fundamental research to deepen our understanding of molecular, pharmacological, pharmacodynamic and pharmacokinetic properties of new molecules in oncology and neurology.

Following through on its open innovation strategy, Ipsen teamed up with Aepodia in a partnership signed in January 2016 covering early-stage development programs in R&D. Aepodia will provide its expertise and agility in early clinical development and in the implementation of Phase I studies up to proof of concept (POC). Aepodia and Ipsen teams will work together to optimize the design of clinical studies and their operational implementation.

> €200 M

Expenditure in R&D in 2016

3

World R&D centers

~300

Employees assigned to R&D

Last update 30/09/2016